No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs
New Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against surrogate advertising of prescription-only medicines, with a specific focus on GLP-1 receptor agonists and …